A new groundbreaking study revealed that recombinant human thyrotropin (SNA001) is as efficient as thyroid hormone withdrawal ...

Noah S. Kalman, MD, MBA, discusses the evolving role of molecular and genetic testing in thyroid cancer management.

Background: High-risk differentiated thyroid cancer in 2015 American Thyroid Association risk stratification system (ATA-RSS) exhibits a significantly increased probability of recurrence and poor ...

Exposure to high-normal, compared with low-normal, TSH levels was not associated with an elevated risk for differentiated thyroid cancer recurrence after thyroidectomy. Exposure to high-normal ...

Recurrent laryngeal injury risk was reduced with intraoperative nerve monitoring among patients with thyroid cancer undergoing thyroidectomy.

A commentary in the Journal of Family Medicine and Primary Care advises primary care clinicians on how to manage patients ...

Follicular thyroid cancer with bone involvement was associated with a significantly elevated risk for brain metastases among women.

Thyroid cancer is cancer of the thyroid gland in the neck. Thyroid cancer affects women more often than men. It has a good prognosis. Risk factors include a family history of this cancer, radiation ...

New research, with the caveat of a relatively short follow-up, adds to encouraging data showing an overall low risk of the development of thyroid cancer associated with glucagon-like peptide 1 ...

The incidence of thyroid cancer in the United States, having plateaued in 2009 after a decades-long increase, has remained stable since then, despite efforts to control an ongoing overdiagnosis of ...

In this issue of The Lancet Diabetes & Endocrinology, Michelle M Chen and colleagues1 report their findings on trends in the incidence of thyroid cancer in the USA from 1975 to 2019. The authors show ...